These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5299668)

  • 1. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4.
    Atanasiu P; Dean DJ; Habel K; Kaplan MM; Koprowski H; Lépine P; Serié C
    Bull World Health Organ; 1967; 36(3):361-5. PubMed ID: 5299668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. II.
    ATANASIU P; BAHMANYAR M; BALTAZARD M; FOX JP; HABEL K; KAPLAN MM; KISSLING RE; KOMAROV A; KOPROWSKI H; LEPINE P; PEREZ GALLARDO F; SCHAEFFER M
    Bull World Health Organ; 1957; 17(6):911-32. PubMed ID: 13511138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of rabies post-exposure treatment with antirabies serum and the human diploid cell vaccine in Iran.
    Bahmanyar M
    Dev Biol Stand; 1978; 40():163-5. PubMed ID: 680390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serovaccination by human immune globulin and HDCS-vaccine against rabies.
    Kuwert EK; Werner J; Marcus I; Cabasso VJ
    Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serum and vaccine in combination for prophylaxis following exposure to rabies.
    Lin FT; Chen SB; Wang YZ; Sun CZ; Zeng FZ; Wang GF
    Rev Infect Dis; 1988; 10 Suppl 4():S766-70. PubMed ID: 3206088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 3.
    ATANASIU P; CANNON DA; DEAN DJ; FOX JP; HABEL K; KAPLAN MM; KISSLING RE; KOPROWSKI H; LEPINE P; PEREZ GALLARDO F
    Bull World Health Organ; 1961; 25(1):103-14. PubMed ID: 13863061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients bitten by rabid or suspected rabid wolves with inactivated tissue culture rabies vaccine and rabies gammaglobulin.
    Selimov MA; Klyueva EV; Aksenova TA; Lebedeva IR; Gribencha LF
    Dev Biol Stand; 1978; 40():141-6. PubMed ID: 79511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man.
    Nicholson KG; Turner GS
    Dev Biol Stand; 1978; 40():115-20. PubMed ID: 680384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidity and magnitude of antibody response to duck-embryo rabies vaccine administered as a pre-exposure regimen.
    Schnurrenberger PR; Anderson GR; Russell JH
    Bull World Health Organ; 1967; 37(4):547-51. PubMed ID: 5301735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine.
    Archer BG; Dierks RE
    Bull World Health Organ; 1968; 39(3):407-17. PubMed ID: 5303907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects.
    Cabasso VJ; Loofbourow JC; Roby RE; Anuskiewicz W
    Bull World Health Organ; 1971; 45(3):303-15. PubMed ID: 5316911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination.
    Wiktor TJ; Lerner RA; Koprowski H
    Bull World Health Organ; 1971; 45(6):747-53. PubMed ID: 5317010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human rabies globulin and human diploid vaccine dose determinations.
    Hafkin B; Alls ME; Baer GM
    Dev Biol Stand; 1978; 40():121-7. PubMed ID: 680385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies post-exposure treatment and side-effects in man using HDC (MRC 5) vaccine.
    Klietmann W; Domres B; Cox JH
    Dev Biol Stand; 1978; 40():109-13. PubMed ID: 567152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody levels following WI38 rabies vaccine.
    Cabasso VJ; Louie RE; Lo B; Dobkin MB
    Dev Biol Stand; 1978; 40():231-5. PubMed ID: 355016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons.
    ATANASIU P; BAHMANYAR M; BALTAZARD M; FOX JP; HABEL K; KAPLAN MM; KISSLING RE; KOMAROV A; KOPROWSKI H; LEPINE P; PEREZ GALLARDO F; SCHAEFFER M
    Bull World Health Organ; 1956; 14(4):593-611. PubMed ID: 13356137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of the large-scale use of PHKC rabies vaccine in humans in China.
    Lin FT
    Bull World Health Organ; 1990; 68(4):449-54. PubMed ID: 2208558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological investigations on rabies tissue culture vaccine (USSR) and development of short methods in post-exposure treatment.
    Sinnecker H; Apitzsch L; Sinnecker R; Selimov M; Giard W; Grimm J; Mueller B; Rasch G; Zilske E
    Dev Biol Stand; 1978; 40():155-8. PubMed ID: 680388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.